David Devigne

David Devigne is a seasoned professional in the fields of venture capital and academia, serving as a Guest Professor at Vlerick Business School and Universiteit Gent since 2009 and 2016, respectively. Currently the Investment Director for Life Sciences at Korys, David leads venture capital investments in health living and life sciences, while also holding significant roles within the Korys management team and investment committee. Additionally, David serves as a Senior Investment Advisor for the OMX Europe Venture Fund and as a Board Member or Observer for various companies, including Aphea.Bio, MIMETAS, Agendia, and reMYND NV. David's academic background includes a Ph.D. in Applied Economics from Ghent University, along with multiple degrees in Economics, Business Administration, and Pharmaceutical Sciences.